This test is most useful if any of these apply to you.
Every cell in your body depends on a molecule called coenzyme A to burn fuel, build fats, and manufacture hormones. Vitamin B5 (pantothenic acid) is the raw material your body uses to make it. If your B5 supply drops, your cells lose access to one of the most widely used helper molecules in human metabolism. Recent research links low plasma B5 to sharply higher odds of type 2 diabetes and cardiovascular complications, making this once overlooked vitamin a surprisingly relevant number to know.
Yet B5 is almost never included on routine blood panels. Standard vitamin testing typically covers B12, folate, and vitamin D, and most physicians assume B5 deficiency is too rare to matter. That assumption is being challenged as studies mapping the small molecules in blood and tissue find that B5 levels are meaningfully altered in diabetes, Parkinson's disease, Alzheimer's disease, and kidney disease. Measuring your blood B5 gives you a window into a metabolic pathway that standard labs completely ignore.
Pantothenic acid is absorbed from food in your intestine and then converted inside your cells into coenzyme A (CoA). CoA is a molecular carrier that shuttles chemical building blocks into hundreds of reactions. It is essential for breaking down carbohydrates, fats, and proteins for energy. It is also required for building fatty acids, cholesterol, steroid hormones like cortisol and testosterone, and the chemical messengers your nervous system uses to communicate.
Humans cannot manufacture pantothenic acid internally, so you depend entirely on dietary intake. The recommended adequate intake for adults is about 5 mg per day. Meat, eggs, dairy, legumes, and whole grains all contain B5. Animal sourced foods tend to be more bioavailable, with roughly 80% of their B5 content absorbed during digestion.
A 2025 study measuring plasma pantothenic acid in people with obesity, type 2 diabetes, and cardiovascular complications found that people with type 2 diabetes had significantly lower plasma B5 levels than healthy controls. Low B5 correlated negatively with blood sugar markers and positively with HDL (the protective cholesterol fraction). Among people in the lowest third of B5 levels, 76.6% had type 2 diabetes.
The risk numbers were striking. People with obesity and low plasma B5 had about 7.6 times the odds of having type 2 diabetes compared to those with higher B5. For diabetes with cardiovascular complications, low B5 was associated with about 12 times the odds in people without obesity and about 7.2 times the odds in people with obesity. These are cross sectional findings, meaning they show a strong association but cannot prove that low B5 causes the disease.
If you already have prediabetes, insulin resistance, or a family history of heart disease, knowing your B5 level adds a data point that your standard metabolic panel does not capture. A low result alongside borderline glucose or elevated triglycerides strengthens the case for early metabolic intervention.
A study using urine samples from people with diabetic kidney disease found that the pantothenic acid and CoA production pathway was significantly disrupted. Urinary pantothenic acid was reduced in people with diabetic kidney disease compared to those with diabetes alone or healthy controls. The researchers proposed that pantothenic acid may serve as a predictive marker for the development and progression of diabetic kidney disease. Because this study measured urine rather than blood, the finding is indirect evidence that B5 metabolism is disturbed in kidney disease, though it does not tell you exactly what your blood B5 level would show.
A pooled analysis of multiple studies found pantothenic acid consistently decreased across multiple Parkinson's disease cohorts, placing it among the metabolites reproducibly altered in PD. Separately, direct measurement of brain tissue in people who had died with Parkinson's disease dementia showed that B5 was significantly lower in the cerebellum (a brain region at the base of the skull involved in movement coordination), the substantia nigra (the brain region most damaged in Parkinson's), and the medulla (the lower brainstem, which controls basic functions like breathing and heart rate).
A parallel line of research found severe, widespread B5 deficiency in brain tissue from Alzheimer's disease cases. The deficiency was worst in the hippocampus, a region central to memory, and in the temporal cortex (a brain area involved in language and memory). Because CoA is required to produce acetylcholine, a chemical nerve cells use to send signals to each other (and which is depleted in Alzheimer's), the researchers proposed that cerebral B5 deficiency may directly contribute to neurodegeneration.
These brain tissue findings come from postmortem studies and measure a different specimen (brain tissue, not blood). Whether blood B5 levels reliably track brain B5 levels has not been firmly established. A low blood level is a signal worth investigating further, but it is not the same as directly measuring your brain's B5 supply.
A cross sectional study of 7,387 adults found that moderate dietary B5 intake was associated with lower odds of anxiety symptoms. This fits with B5's role in producing cortisol and acetylcholine, both of which influence the stress response and nervous system balance. Human depletion studies from the 1950s showed that people deliberately fed a B5 deficient diet developed emotional instability, irritability, and restlessness within weeks.
One prospective observational study of 368 older adults found that higher circulating B5 was associated with greater odds of later cognitive decline, particularly in women and in people who do not carry the ApoE4 gene variant (a genetic risk factor for Alzheimer's). This finding runs in the opposite direction from the brain tissue data showing that low B5 in the brain is harmful.
The apparent contradiction likely reflects the difference between what circulates in blood and what is available inside brain cells. A high blood level could, in some contexts, signal impaired cellular uptake or altered metabolism rather than a surplus of the vitamin where it counts. This is a single study in a specific subgroup, and the finding has not been widely replicated. It does not mean that more B5 causes cognitive decline. It means the relationship between circulating B5 and brain health is more complex than a simple "more is better" framework.
Severe isolated B5 deficiency is rare because the vitamin is found in nearly all foods. But researchers in the 1950s deliberately induced deficiency in healthy young men by feeding them a B5 depleted diet combined with an antagonist drug that blocks B5 activity. Within weeks, participants developed fatigue, headache, weakness, muscle cramps, tingling and numbness in the hands and feet, nausea, abdominal cramping, and rapid heartbeat with drops in blood pressure upon standing.
In real life, you are more likely to see mild B5 insufficiency, where levels are low enough to matter but not severe enough to cause obvious symptoms, than full blown deficiency. People at higher risk include those with severely restricted diets, chronic alcoholism, malabsorption conditions, or prolonged use of medications that impair nutrient absorption.
No major clinical guideline or laboratory standards body has established official reference intervals for blood vitamin B5. The European Food Safety Authority (EFSA) has explicitly stated that "there are no suitable biomarkers that can be used to derive the requirement for pantothenic acid." What follows are research reported values from a small number of studies using different laboratory methods. They should be treated as rough orientation, not clinical targets. Your lab's reported range may differ significantly.
In one study of 63 healthy adolescents measured using an antibody-based detection method, average whole blood pantothenic acid was 344.5 ng/mL in males and 411.9 ng/mL in females. An older study using a different laboratory method in 17 healthy adults found whole blood levels ranging from 30 to 99 ng/mL. A third study in six healthy adults reported values in the range of roughly 197 to 336 ng/mL. These enormous differences across studies show that the laboratory technique used matters far more than any specific cutpoint.
Because there are no consensus clinical thresholds for "low" or "high" blood B5, the most useful approach is to compare your results to the reference range provided by your specific lab and to track your own trend over time.
Acute inflammation and illness can distort circulating levels of water soluble vitamins, including B5. If you are acutely ill, recovering from surgery, or have elevated inflammatory markers like CRP, your B5 result may be artificially low and not representative of your true baseline. Wait until you have recovered before testing.
B complex supplements and energy drinks frequently contain high doses of pantothenic acid, often well above the 5 mg daily intake recommendation. Taking these before a test will inflate your result. Stop B5 containing supplements for at least 48 to 72 hours before your blood draw to get a reading that reflects your natural status.
Medications that reduce nutrient absorption, such as proton pump inhibitors (PPIs, drugs that lower stomach acid) or GLP 1 receptor agonists (weight loss and diabetes drugs that can cause nausea and reduced food intake), may lower B5 levels over time. No specific drug has been proven to shift B5 in isolation, but any medication that causes chronic diarrhea, vomiting, or reduced eating can plausibly lower all water soluble vitamins including B5.
A single B5 reading is a snapshot. Because there are no standardized clinical cutpoints and laboratory methods vary between labs, one number in isolation tells you relatively little. What matters is your trajectory. Get a baseline now so you have something to compare against as more research matures and as your own health changes.
If you are making dietary changes, starting a new supplement, or addressing a condition linked to B5 (like insulin resistance), retest in 3 to 6 months using the same lab and the same method. Comparing results within the same lab over time removes much of the variability that makes cross lab comparisons unreliable. After establishing your trend, annual testing is reasonable for ongoing monitoring.
This is a newer measurement without standardized cutpoints, but that is exactly why getting a baseline now and tracking your trend gives you a head start. You will have your own data to compare against as the science matures.
If your B5 comes back low, the first step is to rule out obvious causes. Are you eating a very restricted diet? Are you taking medications that impair absorption? Have you been acutely ill? If none of those apply, consider ordering companion tests to build a fuller picture: fasting glucose and HbA1c (a three-month average of blood sugar, relevant given the diabetes link), a complete metabolic panel to assess kidney function, and B12 and folate to check whether the low B5 is part of a broader B vitamin pattern.
If your B5 is low alongside signs of insulin resistance (elevated fasting insulin, rising HbA1c, or high triglycerides), that pattern strengthens the case for metabolic investigation. An endocrinologist or a physician focused on metabolic health can help interpret the constellation of findings. If B5 is low alongside neurological symptoms like tingling, fatigue, or cognitive changes, a neurologist may be appropriate.
If your result is high, consider whether recent supplementation or high dose B complex use explains it. In the absence of supplementation, a high B5 level in the context of metabolic disease or cancer risk factors may warrant further evaluation, though the clinical significance of elevated blood B5 is still being studied.
Evidence-backed interventions that affect your Vitamin B5 level
Vitamin B5 is best interpreted alongside these tests.